John Nosta

First and foremost, John is a thinker. A thinker entrenched in the world of technology, science, medicine and innovation. John is the founder of NOSTALAB—a innovation think tank recognized globally for an inspired vision of transformation.   He’s currently ranked as one of the leading global influencers in innovation and technology and well established as one of the top global strategic and creative thinkers. He is also one the most popular speakers around the globe presenting his vibrant and insightful perspective on the future on innovation. His focus is on guiding companies, NGOs, and governments through the dynamics of exponential change and the diffusion of innovation into complex systems.

Unwilling to accept the status quo, he’s a contrarian with a sharp focus on the future. A leading voice in the convergence of technology and humanity, Nosta helps define, dissect and deliberate global trends in technology. Beyond simply an influencer, John is also defined as “most admired” to “top disruptor” in technology, innovation, life sciences and the pharmaceutical industry. He is also a member of the Google Health Advisory Board and a consultant for ARK Invest. John is also a frequent and popular contributor to Fortune, Forbes, Psychology Today and Bloomberg. He has also been published in prestigious peer-reviewed journals including The American Journal of Physiology, Circulation, and The American Journal of Hematology. In 2018, he received a PhD, honoris causa from Udabol Internacional: Oficial Universidad de Aquino Bolivia and from the Latin America Foundation, University of Science and Informatics Peru and Centre for Neuroscience.  He was also awarded the diploma of honour from the Bolivian government for his work in health technology in promoting innovation and engagement around the world. In 2019, he was named a founding member of the  World Health Organization’s Digital Health Roster of Experts. Nosta has also created the Technology Quotient or TQ that helps quantify and shape the human relationship with technology.

John has an established reputation as a vocal advocate for strategic thinking and creativity. He has built his career on the “science of innovation,” a process where strategy and creativity work together to create inflection points in the market. He has also been recognized for his ability to translate difficult medical and scientific concepts into material that can be more easily communicated to consumers, clinicians and scientists. Additionally, John has distinguished himself as a scientific thinker. Earlier in his career, John was a research associate at Harvard Medical School and has co-authored several papers with global thought-leaders in the field of cardiovascular physiology with a focus on cell volume regulation, acute myocardial infarction, ventricular arrhythmias and sudden cardiac death. John also distinguish himself as one of the youngest authors to be published a major peer-reviews publications in Harvard’s history.

John cut his teeth at the “big” agencies including Ogilvy CommonHealth, where he has held a series of positions including Chief Creative Officer, Chief Strategic Officer and unit President.